Marker Therapeutics Inc MRKR Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Marker Therapeutics Inc (MRKR)
Marker Therapeutics Inc (MRKR) Financials

Marker Therapeutics Inc (MRKR)

3.19

-0.07

(-2.15%)

Closed November 27 3:00PM

Delayed by 15 minutes

3.42

0.23

(7.21%)

After Hours: 5:55PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-33.709	-167.651	-439.54	-39.498	-62.422	-73.633	-58.369	-31.958
Return on Equity (%)	32.356	-223.143	-469.715	-41.436	-80.374	-117.422	-94.142	-48.951
Return on Invested Capital (%)	111.921	-236.981	-470.395	-43.565	-80.878	-110.69	-94.189	-86.682
Operating Margin (%)	N/A	N/A	-71824.272	-10060.094	-6146.895	-3371.9	-332.087	-424.101
Net Profit Margin (%)	N/A	N/A	-71824.272	-10060.094	-6146.895	-3371.9	-332.087	-248.777
Book Value Per Share	0.734	0.345	1.307	0.965	0.539	0.529	0.233	1.581
Earnings Per Share	-0.292	-1.036	-3.259	-0.469	-0.566	-0.504	-0.356	-0.927
Cash Per Share	0.932	0.484	1.36	0.961	0.421	0.51	0.14	1.7
Working Capital Per Share	0.734	0.345	1.304	0.952	0.355	0.398	0.105	1.581
Operating Profit Per Share	N/A	N/A	0.005	0.005	0.009	0.015	0.107	0.372
EBIT Per Share	-0.292	-1.036	-3.259	-0.469	-0.566	-0.504	-0.356	-1.58
EBITDA Per Share	-0.292	-1.036	-3.259	-0.469	-0.566	-0.504	-0.356	-1.58
Free Cash Flow Per Share	-0.292	-1.036	-3.256	-0.463	-0.37	-0.492	-0.331	-0.927

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	8.42M	10.6M	45.4M	45.7M	50.7M	83.1M	84M	N/A

Key Stats and Ratios

Year End December 30 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	83.6M	84M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-104.943	N/A	N/A	N/A	-192.363	N/A
Net Profit Margin (%)	N/A	N/A	-104.943	N/A	N/A	N/A	-192.363	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	29.09M
Price to Earnings Ratio	-3.73
Price to Sales Ratio	9.27
Price to Cash Ratio	2.03
Price to Book Ratio	2.18
Dividend Yield	-

Share Statistics

Shares Outstanding	8.92M
Average Volume (1 week)	38.09k
Average Volume (1 Month)	29.86k
52 Week Change	26.20%
52 Week High	6.1568
52 Week Low	2.4377

More Ratios Coming Soon!

Marker Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions